# Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-23 14:29 UTC · Category: Business · Sources: 5 · Current Velocity: 2.8

## Key People, Organizations & Locations
Study, Target, Disease, Roche, Late-Stage, Hits, Drug, Candidate, Autoimmune

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| The Clinical Trial Vanguard | Roche’s Sefaxersen Meets Primary Endpoint in Phase 3 IgAN Study | 2026-09-23 06:11 | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxQc0d6T2ItampoekNBOHk5MWFXems1Y3dNaGtLYXRrUzNpSDBtVW5VZlk2NEJpNkV5NXJLdjZ6a0VmWUhPMjhJeElhYzZKNkZFTGQyNmhWUE13eTVuaUVJXzUtNzFrMlptUDcyb2tHRGpkRnBldWVscmV6a0djNE9UaWhpaEZKZ21DdUxPeWhWVy14NmVNMEhKZ0ZmRk1Gd3V3elBnTWdVUThxUQ?oc=5) |
| Investing.com India | Form 8K IONIS PHARMACEUTICALS For: 23 September By Investing.com | 2026-09-23 06:11 | [Source Link](https://news.google.com/rss/articles/CBMiqwFBVV95cUxQaXl1MWRwNndSVlFHVU0yRVRTZFRWbUo5V2ZBb3VxdnF5WG1aaTFzZjFOUFNmQVEtWlY2UURoWng5dWdFck5iY011d0xDTHJEMWxKLXhmdG16MHcwVVJxN3FRNW5UOHFvS2c2UEJCQWhPRGxtS3pnaG5mbGVkbHdJSGdLampuU1l5OW5LMjdwdzY3WExzdzRZb2dCUWZaRk80Z0UybEg5a1FvQ1U?oc=5) |
| Endpoints News | Roche kidney drug’s Phase 3 win sets up path to accelerated approval | 2026-09-23 06:11 | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxNRWdkSjNXRkhxbXN6bmJMQUZtOVd6bEdWUWprLUNMb3VhYzBXb1JfaXUzbGlCcjEwbXliQzdOajhpRGZJZDF1Y1QtVXJIc2dRUVIyQlYwbjdmaXJjQ2paZ0RSU3BvWkdkOEpiQ3hkUXA4MWl1MlRhUjduRlh4a0FLR1lfU01QbE5HaHR0U3FZVGg0MHZnb0E?oc=5) |
| Fierce Biotech | Roche’s phase 3 win tees up fight with Novartis for blockbuster kidney disease market | 2026-09-23 06:11 | [Source Link](https://news.google.com/rss/articles/CBMirwFBVV95cUxQUzExc3FTRW02c1Zqa3RyR1VMNUJkQVBsM1VqODJZVVZpdWZDYWFCLWo1N1JWYlUwN3RtRm9YUllfT2EyOGNCQ29MeE1KTE5sWE9mTF8wN1BHYnV6OXlQZ1ZNdFgwMzdQR01QMWg3WVpzWWNxU1BBaTQ0NXh6SEV2NjNSNlNPSW5SNE9XNlZzbWc4enZRNFUzRnZGdThVUXNOVTVqRGVkanNuVmhJY2Mw?oc=5) |
| WSJ | Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease | 2026-09-23 06:11 | [Source Link](https://news.google.com/rss/articles/CBMiugFBVV95cUxOTHdENDgzNGg3MDh4UFZPd0d3TkF2QlpMa0lvOWNGSU9uZlFfSkd2QTZUNWRONVhudC1DZng2TUp2eWpYSXhHNTBxODlTODNaTWVlNmdzSUo3X2JDTi1SMVhkcjlPcl9vRGlUZ011MTRadzVLMHBuVEZrUzB0Qm1UajZicVNQUEFBbEhPVnVjN3M2MTM5ZUFNRmpuZjhOeXRCRmRTMWMyU2M3WTgyRVFRWDJfRzdTdjJZeXc?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-23/roche-drug-candidate-hits-target-in-late-stage-study-for-autoimmune-disease*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*